Last reviewed: June 1, 2026 Last updated: June 1, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Incretins Introduction Type 2 diabetes may result from a variety of conditions including -cell dysfunction, where insulin is not produced, and/or due to insulin resistance, in both cases leading to hyperglycemia, and complications in both small and large blood vessels (Silberstein, 2013)
The results have been beyond my expectations
Service Members who are overweight with other risk factors or obese should work with their Department of War (DoW) medical officer or Primary Care Manager/Provider to determine if a GLP-1 medication is appropriate before starting these medications
Cancer Chemother Pharmacol 61(4):579585
This segment is the tactical heart of the episode: protect your lean mass and nutrient intake while still benefiting from appetite control
